Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 86 páginas
Examen

PHM 203 PCT 4 Infectious Diseases Midterm 2 | 800+ Exam Questions & Verified Answers | Influenza, Pneumonia, Tuberculosis, Endocarditis & Pharmacotherapy

Document preview thumbnail
Vista previa 4 fuera de 86 páginas

Ace PHM 203 – PCT 4 Infectious Diseases Midterm 2 with this comprehensive study guide featuring 800+ exam questions and verified answers covering the essential concepts of infectious diseases, antimicrobial pharmacotherapy, respiratory tract infections, tuberculosis, cardiovascular infections, gastrointestinal infections, pharmaceutical dosage forms, and clinical therapeutics. This exam-focused resource provides extensive coverage of influenza (antigenic drift and shift, diagnosis, antiviral therapy, vaccination), community-acquired and hospital-acquired pneumonia, ventilator-associated pneumonia, COVID-19, tuberculosis, infective endocarditis, peritonitis, intra-abdominal infections, biliary tract infections, travel medicine, antimicrobial selection, empiric and targeted therapy, pharmacokinetics, pharmaceutical suspensions, parenteral drug delivery systems, liposomes, nanomedicines, and anti-tuberculosis pharmacotherapy. Organized in a structured question-and-answer format, this study guide strengthens clinical reasoning, reinforces evidence-based therapeutic principles, and prepares students for midterm examinations, comprehensive assessments, and pharmacy practice evaluations. The material progresses systematically from respiratory viral infections and pneumonia through hospital-acquired infections, influenza management, COVID-19 therapeutics, tuberculosis diagnosis and RIPE therapy, infective endocarditis, intra-abdominal infections, peritonitis, and advanced pharmaceutical dosage formulations, providing an integrated review of infectious disease pharmacotherapy and pharmaceutical sciences. Students will master critical topics including CURB-65 scoring, antimicrobial resistance, empiric versus targeted antibiotic therapy, Legionella infections, atypical pathogens, TB screening and treatment, latent versus active tuberculosis, anti-TB drug mechanisms, adverse effects, monitoring parameters, pharmaceutical suspensions, flocculated and deflocculated systems, liposomal drug delivery, injectable nanomedicines, and parenteral formulations. This resource serves as an excellent revision tool for mastering both foundational pharmaceutical sciences and clinical infectious disease management. The academic references below are recommended for supplementary learning and are not the original source of the uploaded examination questions and answers. Academic References (APA 7th Edition): Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2023). Goodman & Gilman's The Pharmacological Basis of Therapeutics (14th ed.). McGraw Hill. DiPiro, J. T., Yee, G. C., Posey, L. M., Haines, S. T., Nolin, T. D., & Ellingrod, V. (2023). Pharmacotherapy: A Pathophysiologic Approach (12th ed.). McGraw Hill. Mandell, G. L., Bennett, J. E., & Dolin, R. (2020). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (9th ed.). Elsevier. Katzung, B. G., & Trevor, A. J. (2024). Basic and Clinical Pharmacology (16th ed.). McGraw Hill. Relevant Students: This study guide is ideal for students enrolled in Pharmacy, Pharmaceutical Sciences, Clinical Pharmacy, Pharmacology, Medicine, Nursing, Biomedical Sciences, Medical Laboratory Science, Physician Assistant, Public Health, Health Sciences, Microbiology, Infectious Diseases, and other healthcare programs studying infectious diseases, antimicrobial therapy, clinical pharmacotherapy, and pharmaceutical dosage forms, particularly those preparing for PHM 203 PCT 4 Infectious Diseases Midterm 2. Keywords: PHM 203, PCT 4, infectious diseases, infectious disease pharmacotherapy, pharmacotherapy, clinical pharmacy, influenza, influenza A, influenza B, antigenic drift, antigenic shift, antiviral therapy, oseltamivir, zanamivir, amantadine, COVID-19, Paxlovid, pneumonia, community acquired pneumonia, hospital acquired pneumonia, ventilator associated pneumonia, atypical pneumonia, Legionella, Mycoplasma pneumoniae, Chlamydia pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, CURB-65, respiratory infections, tuberculosis, latent TB, active TB, RIPE therapy, isoniazid, rifampin, pyrazinamide, ethambutol, BCG vaccine, interferon gamma release assay, TB skin test, infective endocarditis, Duke criteria, vegetation, bacteremia, peritonitis, intra-abdominal infections, diverticulitis, cholangitis, pyogenic liver abscess, antimicrobial therapy, empiric therapy, targeted therapy, antibiotic stewardship, pharmaceutical suspensions, flocculated suspensions, deflocculated suspensions, Stokes law, parenteral formulations, injectable medications, liposomes, nanomedicine, drug delivery systems, pharmaceutical dosage forms, clinical microbiology, exam questions, verified answers, study guide, midterm preparation

Vista previa del contenido

PHM 203 - PCT 4 Infectious
Diseases Midterm 2 2026 Exam
Questions and Answers |
Already Graded A+



Which antigenic phenomenon causes epidemics? - ANSWER

✔✔Antigenic Drift


Which antigenic phenomenon has variants created by point mutations in

the surface antigens of a particular subtype, resulting in small changes

in hemagglutinin and/or neuraminidase molecules? - ANSWER

✔✔Antigenic Drift

,Which antigenic phenomenon is why there are changes in the annual

influenza vaccine, and the rationale behind the recommendation for

annual vaccination? - ANSWER ✔✔Antigenic Drift


Which antigenic phenomenon causes pandemics? - ANSWER

✔✔Antigenic Shift


Which antigenic phenomenon occurs when the virus acquires a new

hemagglutinin and/or neuraminidase via genetic reassortment? -

ANSWER ✔✔Antigenic Shift


Which antigenic phenomenon may result in the emergence of a novel

influenza virus, but must also be able to replicate in humans, spread

person-to-person, or affect a susceptible population? - ANSWER

✔✔Antigenic Shift


How is influenza transmitted? - ANSWER ✔✔1. Large particle

droplets 2. Sneezing, coughing (respiratory) 3. Close contact

When does influenza start to shed, and what is the average duration of

shedding? - ANSWER ✔✔1-2 days before illness onset, 5 days

(longer duration in children, elderly, chronic illnesses,

immunocompromised hosts)

,What term describes an acute infection of the pulmonary parenchyma? -

ANSWER ✔✔Pneumonia


Which type of pneumonia is acquired in the hospital? - ANSWER

✔✔Nosocomial pneumonia


Which type of pneumonia is acquired in the community? - ANSWER

✔✔Community acquired pneumonia (CAP)


Which type of nosocomial pneumonia is acquired after being admitted to

hospital for ≥ 48 hours? - ANSWER ✔✔Hospital acquired pneumonia

(HAP)

Which type of nosocomial pneumonia is acquired after being intubated

for ≥ 48 hours? - ANSWER ✔✔Ventilator associated pneumonia


What term describes the potion of the lungs involved in gas exchange,

and are made up of thin walled alveoli? - ANSWER ✔✔Parenchyma


What is the usual pathophysiology of lung infections? - ANSWER

✔✔1. Pathogens accessing the lower respiratory tract 2. Impairment of

host defenses to clear microorganisms from lungs 3. Inflammation




3
COPYRIGHT©JOSHCLAY 2025/2026. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED

, Which type of pneumonia is one of the most common causes of severe

sepsis and is the leading infectious cause of death? - ANSWER

✔✔Community acquired pneumonia (CAP)


What are the ways that pathogens enter the lower airway? -

ANSWER ✔✔1. Aspiration of oropharyngeal contents (normal flora in

the oropharynx) 2. Direct inhalation (environmental pathogens) 3.

Hematogenous spread (through the blood → lungs)


What are the complications of pneumonia? - ANSWER ✔✔1.

Bacteremia and sepsis 2. Lung abscess 3. Empyema 4. Necrotizing

pneumonia 5. Death BLENDing pus in the lungs


What are the risk factors for pneumonia? - ANSWER ✔✔1. Age >65

2. Diabetes 3. Asplenia 4. Chronic CV, pulmonary, renal, or liver disease

5. Smoking and/or alcohol abuse


What is common within the risk factors for pneumonia? - ANSWER

✔✔Decreases the capability of lungs to clear organisms


In pneumonia, which organisms are involved when there is aspiration of

oropharyngeal contents? - ANSWER ✔✔1. H. influenzae 2. S.

pneumoniae 3. M. catarrhalis

Información del documento

Subido en
3 de agosto de 2026
Número de páginas
86
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$18.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
JOSHCLAY
3.5
(82)
Vendido
382
Seguidores
16
Artículos
20301
Última venta
1 día hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes